Page last updated: 2024-08-22
tiletamine hydrochloride and Granulocytic Leukemia
tiletamine hydrochloride has been researched along with Granulocytic Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Higashihara, M; Horie, R; Nakashima, M; Togano, T; Umezawa, K; Watanabe, M; Watanabe, T | 1 |
Other Studies
1 other study(ies) available for tiletamine hydrochloride and Granulocytic Leukemia
Article | Year |
---|---|
Synergistic effect of 5-azacytidine and NF-κB inhibitor DHMEQ on apoptosis induction in myeloid leukemia cells.
Topics: Apoptosis; Azacitidine; Benzamides; Cell Line, Tumor; Cyclohexanones; Drug Synergism; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; NF-kappa B; Tumor Cells, Cultured | 2012 |